Report Detail
Global Drugs for Schistosomiasis Market Insights, Forecast to 2025
- RnM3357397 |
- 27 April, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.
The global average price of Drugs for Schistosomiasis is in the decreasing trend, from 62 USD/K Units in 2011 to 57 USD/K Units in 2015. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Drugs for Schistosomiasis is Praziquantel, Oxamniquine and other. Praziquantel is the mainly drug for Schistosomiasis, and the proportion of Praziquantel in 2015 is about 90%.
Drugs for Schistosomiasis are widely used in S. haematobium, S. mansoni, S. japonicum, S. mekongi and S. intercalatum.Most of human infections are caused by S. haematobium, S. mansoni, S. japonicum. And the market share used in S. haematobium in 2015 is 28%. And the market share used in S. mansoni in 2015 is 48%.
The global Drugs for Schistosomiasis market is valued at 70 million US$ in 2018 and will reach 94 million US$ by the end of 2025, growing at a CAGR of 3.8% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Drugs for Schistosomiasis market based on company, product type, end user and key regions.
This report studies the global market size of Drugs for Schistosomiasis in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Drugs for Schistosomiasis in these regions.
This research report categorizes the global Drugs for Schistosomiasis market by top players/brands, region, type and end user. This report also studies the global Drugs for Schistosomiasis market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals
Market size by Product
Praziquantel
Oxamniquine
Other
Market size by End User
S. haematobium
S. mansoni
S. japonicum
S. mekongi
S. intercalatum
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Drugs for Schistosomiasis market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Drugs for Schistosomiasis market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Drugs for Schistosomiasis companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Drugs for Schistosomiasis submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Drugs for Schistosomiasis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (M Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Drugs for Schistosomiasis market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Drugs for Schistosomiasis Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Drugs for Schistosomiasis Market Size Growth Rate by Product
- 1.4.2 Praziquantel
- 1.4.3 Oxamniquine
- 1.4.4 Other
- 1.5 Market by End User
- 1.5.1 Global Drugs for Schistosomiasis Market Size Growth Rate by End User
- 1.5.2 S. haematobium
- 1.5.3 S. mansoni
- 1.5.4 S. japonicum
- 1.5.5 S. mekongi
- 1.5.6 S. intercalatum
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Drugs for Schistosomiasis Market Size
- 2.1.1 Global Drugs for Schistosomiasis Revenue 2014-2025
- 2.1.2 Global Drugs for Schistosomiasis Sales 2014-2025
- 2.2 Drugs for Schistosomiasis Growth Rate by Regions
- 2.2.1 Global Drugs for Schistosomiasis Sales by Regions
- 2.2.2 Global Drugs for Schistosomiasis Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Drugs for Schistosomiasis Sales by Manufacturers
- 3.1.1 Drugs for Schistosomiasis Sales by Manufacturers
- 3.1.2 Drugs for Schistosomiasis Sales Market Share by Manufacturers
- 3.1.3 Global Drugs for Schistosomiasis Market Concentration Ratio (CR5 and HHI)
- 3.2 Drugs for Schistosomiasis Revenue by Manufacturers
- 3.2.1 Drugs for Schistosomiasis Revenue by Manufacturers (2014-2019)
- 3.2.2 Drugs for Schistosomiasis Revenue Share by Manufacturers (2014-2019)
- 3.3 Drugs for Schistosomiasis Price by Manufacturers
- 3.4 Drugs for Schistosomiasis Manufacturing Base Distribution, Product Types
- 3.4.1 Drugs for Schistosomiasis Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Drugs for Schistosomiasis Product Type
- 3.4.3 Date of International Manufacturers Enter into Drugs for Schistosomiasis Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Drugs for Schistosomiasis Sales by Product
- 4.2 Global Drugs for Schistosomiasis Revenue by Product
- 4.3 Drugs for Schistosomiasis Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Drugs for Schistosomiasis Breakdown Data by End User
6 North America
- 6.1 North America Drugs for Schistosomiasis by Countries
- 6.1.1 North America Drugs for Schistosomiasis Sales by Countries
- 6.1.2 North America Drugs for Schistosomiasis Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Drugs for Schistosomiasis by Product
- 6.3 North America Drugs for Schistosomiasis by End User
7 Europe
- 7.1 Europe Drugs for Schistosomiasis by Countries
- 7.1.1 Europe Drugs for Schistosomiasis Sales by Countries
- 7.1.2 Europe Drugs for Schistosomiasis Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Drugs for Schistosomiasis by Product
- 7.3 Europe Drugs for Schistosomiasis by End User
8 Asia Pacific
- 8.1 Asia Pacific Drugs for Schistosomiasis by Countries
- 8.1.1 Asia Pacific Drugs for Schistosomiasis Sales by Countries
- 8.1.2 Asia Pacific Drugs for Schistosomiasis Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Drugs for Schistosomiasis by Product
- 8.3 Asia Pacific Drugs for Schistosomiasis by End User
9 Central & South America
- 9.1 Central & South America Drugs for Schistosomiasis by Countries
- 9.1.1 Central & South America Drugs for Schistosomiasis Sales by Countries
- 9.1.2 Central & South America Drugs for Schistosomiasis Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Drugs for Schistosomiasis by Product
- 9.3 Central & South America Drugs for Schistosomiasis by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Drugs for Schistosomiasis by Countries
- 10.1.1 Middle East and Africa Drugs for Schistosomiasis Sales by Countries
- 10.1.2 Middle East and Africa Drugs for Schistosomiasis Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Drugs for Schistosomiasis by Product
- 10.3 Middle East and Africa Drugs for Schistosomiasis by End User
11 Company Profiles
- 11.1 Shin Poong
- 11.1.1 Shin Poong Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Shin Poong Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Shin Poong Drugs for Schistosomiasis Products Offered
- 11.1.5 Shin Poong Recent Development
- 11.2 Merck
- 11.2.1 Merck Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Merck Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Merck Drugs for Schistosomiasis Products Offered
- 11.2.5 Merck Recent Development
- 11.3 Bayer
- 11.3.1 Bayer Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Bayer Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Bayer Drugs for Schistosomiasis Products Offered
- 11.3.5 Bayer Recent Development
- 11.4 EIPICO
- 11.4.1 EIPICO Company Details
- 11.4.2 Company Business Overview
- 11.4.3 EIPICO Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 EIPICO Drugs for Schistosomiasis Products Offered
- 11.4.5 EIPICO Recent Development
- 11.5 Chandra Bhagat Pharma
- 11.5.1 Chandra Bhagat Pharma Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Chandra Bhagat Pharma Drugs for Schistosomiasis Products Offered
- 11.5.5 Chandra Bhagat Pharma Recent Development
- 11.6 Taj Pharmaceuticals
- 11.6.1 Taj Pharmaceuticals Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Taj Pharmaceuticals Drugs for Schistosomiasis Products Offered
- 11.6.5 Taj Pharmaceuticals Recent Development
12 Future Forecast
- 12.1 Drugs for Schistosomiasis Market Forecast by Regions
- 12.1.1 Global Drugs for Schistosomiasis Sales Forecast by Regions 2019-2025
- 12.1.2 Global Drugs for Schistosomiasis Revenue Forecast by Regions 2019-2025
- 12.2 Drugs for Schistosomiasis Market Forecast by Product
- 12.2.1 Global Drugs for Schistosomiasis Sales Forecast by Product 2019-2025
- 12.2.2 Global Drugs for Schistosomiasis Revenue Forecast by Product 2019-2025
- 12.3 Drugs for Schistosomiasis Market Forecast by End User
- 12.4 North America Drugs for Schistosomiasis Forecast
- 12.5 Europe Drugs for Schistosomiasis Forecast
- 12.6 Asia Pacific Drugs for Schistosomiasis Forecast
- 12.7 Central & South America Drugs for Schistosomiasis Forecast
- 12.8 Middle East and Africa Drugs for Schistosomiasis Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Drugs for Schistosomiasis Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Drugs for Schistosomiasis. Industry analysis & Market Report on Drugs for Schistosomiasis is a syndicated market report, published as Global Drugs for Schistosomiasis Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Drugs for Schistosomiasis market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
